Hvsen Biotechnology Co., Ltd.

SZSE:300871.SZ

14.16 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Omzet 356.25227.161204.501328.373242.304218.67230.412351.422274.46191.353205.666250.307210.17222.239313.5281.082209.553151.821135.002158.86786.962
Kosten van de omzet 308.89204.352159.934261.74195.988174.036174.702266.031213.392156.554164.18211.772155.857148.369209.497180.089132.48994.15282.85896.7456.494
Brutowinst 47.35922.80944.56766.63346.31644.63455.7185.39161.06834.79941.48638.53554.31373.87104.003100.99377.06357.6752.14462.12730.469
Brutowinstmarge 0.1330.10.2180.2030.1910.2040.2420.2430.2230.1820.2020.1540.2580.3320.3320.3590.3680.380.3860.3910.35
Onderzoek- en ontwikkelingskosten 12.4919.77314.53513.39111.9669.9549.2862.358.2097.9269.75418.76912.989.2245.91512.616.5795.5483.6455.7834.793
Algemene en administratieve kosten 47.323-13.37918.413-41.5146.039-10.50916.52512.66435.255-7.9313.562-13.00220.5941.8917.845-9.0259.793-1.1255.284-42.1655.323
Verkoop- en marketingkosten 29.08814.65914.34214.76614.58113.22213.05915.37711.6589.1812.192.84813.06915.62715.6118.89312.09711.3410.22610.9338.22
Verkoop-, algemene en administratieve kosten 76.41120.58428.581-26.74560.6212.71229.58436.49846.9131.24925.752-10.15433.66217.51823.4559.86821.8910.21515.51-31.23213.543
Overige kosten -45.042-1.06-2.037-0.293-0.095-2.2660.01217.82-0.0120.045-2.0050.16-0.049-0.165-0.142-0.4160.024-0.002-0.092.9980.002
Bedrijfskosten 43.8631.41745.15247.31445.33242.0536.66356.66835.01230.60336.02732.06435.49735.70531.26441.49123.30425.02420.0321.56718.473
Bedrijfsresultaat -1.224-8.608-0.585-1.906-2.6282.99716.61928.72320.0685.5664.79912.90519.92544.56673.63263.05252.46831.49929.49838.07610.508
Bedrijfsresultaat ratio -0.003-0.038-0.003-0.006-0.0110.0140.0720.0820.0730.0290.0230.0520.0950.2010.2350.2240.250.2070.2190.240.121
Totaal overige inkomsten en kosten netto 4.707-34.532-20.961-0.293-0.095-2.2660.012-0.474-0.0120.045-2.0050.16-0.049-0.165-0.142-0.4160.024-0.002-0.09-0.0210.002
Inkomen voor belasting 3.482-43.14-21.546-2.199-2.7230.73216.63128.24920.0565.6112.79413.06519.87644.40273.48962.63652.49231.49729.40838.05510.509
Inkomen voor belasting ratio 0.01-0.19-0.105-0.007-0.0110.0030.0720.080.0730.0290.0140.0520.0950.20.2340.2230.250.2070.2180.240.121
Belastingkosten -0.781-7.667-5.14-4.103-1.702-0.311.7761.9490.1621.1220.77-0.0711.4756.53110.0329.4238.1134.2554.0844.9061.189
Nettowinst 4.22-35.473-16.4061.903-1.0211.04214.85626.319.8934.4892.02413.13718.40137.87163.45753.21244.37927.24225.32433.1499.32
Nettowinstmarge 0.012-0.156-0.080.006-0.0040.0050.0640.0750.0720.0230.010.0520.0880.170.2020.1890.2120.1790.1880.2090.107
WPA (Winst Per Aandeel) 0.026-0.22-0.0990.012-0.0060.0060.0910.160.120.0270.010.0790.110.230.380.260.320.110.210.270.073
Verwaterde WPA 0.026-0.22-0.0990.012-0.0060.0060.0910.160.120.0270.010.0790.110.230.380.260.320.110.210.270.073
EBITDA 16.16219.0784.8242.61236.69632.87649.14543.28346.27919.87116.84524.15330.44549.54479.4162.89753.03836.24132.05238.51813.905
EBITDA ratio 0.0450.0840.0240.0820.0220.0160.0890.1230.0870.0470.0330.0320.10.1840.2430.2250.2660.2170.2370.2760.142